[1] Brunoni AR,Boggio PS .2008 .Can the 'yin and yang' BDNF hypothesis be used to predict the effects of rTMS treatment in neuropsychiatry? Med. , 71(2) : 279-282.
[2] Chen F,Chen S,Si A,Luo Y,Hu W,Zhang Y .2022 .The long-term trend of Parkinson's disease incidence and mortality in China and a Bayesian projection from 2020 to 2030. , 14 : 973310.
[3] Chen X,Xiu H,Hou Y,Chen X,Liu F,Tu S F .2024 .High-frequency repetitive transcranial magnetic stimulation on overall cognition in patients with poststroke cognitive impairment: A systematic review and meta-analysis. Am. J. Phys. Med, 103(5) : 418-427.
[4] Cho SS,Strafella AP .2009 .rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One, 4(8) : e6725.
[5] Fahn S and Elton R,Marsden C,Calne D .1987 .Unified Parkinson's disease rating scale. , 2 : 153-164.
[6] Kamble N,Netravathi M,Pal PK M .2014 .Therapeutic applications of repetitive transcranial magnetic stimulation (rTMS) in movement disorders: A review. Parkinsonism Relat, 20(7) : 695-707.
[7] Karikari TK,Charway-Felli A,Hoglund K,Blennow K,Zetterberg H K .2018 .Front. , 9 : 201.
[8] Karuka AH,Silva JA,Navega MT .2011 .Analysis of agreement of assessment tools of body balance in the elderly. Rev. Bras. Fisioter, 15(6) : 460-466.
[9] King LA,Peterson DS,Mancini M,Carlson-Kuhta P,Fling BW,Smulders K,Nutt JG,Dale M,Carter J,Winters-Stone KM,Horak FB .2015 .Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease: A randomized clinical trial. BMC Neurol, 15 : 218.
[10] Li J,Lou Z,Liu X,Sun Y,Chen J .2017 .Efficacy and safety of adjuvant treatment with entacapone in advanced parkinson's disease with motor fluctuation: A systematic meta-analysis. Eur. Neurol., 78(3-4) : 143-153.
[11] Liao X,Wu N,Liu D,Shuai B,Li S,Li K .2020 .Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: A meta-analysis. Neurol Sci., 41(8) : 2045-2054.
[12] Marras C,Rochon P,Lang AE .2002 .Predicting motor decline and disability in Parkinson disease: A systematic review. Arch. Neurol., 59(11) : 1724-1728.
[13] Michael P,Constantinou Juhasz SB,Evagorou O,Psalta L,Mikellides G .2022 .High-frequency rTMS improves quality of life and depressive symptoms in Parkinson's disease: A case report. Heliyon, 8(12) : e12196.
[14] Muslimovic D,Post B,Speelman JD,Schmand B,de Haan RJ .2008 .Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology, 70(23) : 2241-2247.
[15] Nasreddine ZS,Phillips NA,Bedirian V,Charbonneau S,Whitehead V,Collin I,Cummings JL,Chertkow H JL .2005 .The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc., 53(4) : 695-699.
[16] Pal E,Nagy F,Aschermann Z,Balazs E,Kovacs N E .2010 .The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study. Mov. Disord, 25(14) : 2311-2317.
[17] Peto V,Jenkinson C,Fitzpatrick R,Greenhall R .1995 .The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual. Life Res., 4(3) : 241-248.
[18] Scherfer E,Bohls C,Freiberger E,Heise KF,Hogan DJP .2006 .Berg-Balance-Scale - Deutsche version. , 2(2) : 59-66.
[19] Schrag A,Jahanshahi M,Quinn N M .2000 .How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov, 15(6) : 1112-1118.
[20] Senek M,Nielsen EI,Nyholm D EI .2017 .Levodopaentacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study. Mov. Disord, 32(2) : 283-286.
[21] Thanakamchokchai J,Tretriluxana J,Pakaprot N,Pisarnpong A,Fisher BE .2020 .Effects of highfrequency repetitive transcranial magnetic stimulation on reach-to-grasp performance in individuals with Parkinson's disease: A preliminary study. Exp. Brain Res., 238(9) : 1827-1837.
[22] Wang Y,Ding Y,Guo C Y .2024 .Assessment of noninvasive brain stimulation interventions in Parkinson's disease: A systematic review and network meta-analysis. Sci. Rep, 14(1) : 14219.
[23] Xie CL,Chen J,Wang XD,Pan JL,Zhou Y,Lin SY,Xue XD,Wang WW .2015 .Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: A meta-analysis of randomized controlled clinical trials. Neurol. Sci., 36(10) : 1751-1761.
[24] Yuan Y,Wu Y,Zhao H,Ren J,Su W,Kou Y,Wang Q,Cheng J,Tong Z J .2013 .Tropospheric formaldehyde levels infer ambient formaldehydeinduced brain diseases and global burden in China,. , 883 : 163553.